Dornase Alfa
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
The Alfred
Overview
Dornase Alfa is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Dornase Alfa clinical trials
Explore related
Medical disclaimer. This page summarizes research about Dornase Alfa for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.